BTCY - Biotricity - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

BTCY is currently covered by 2 analysts with an average price target of $9.82. This is a potential upside of $8.54 (667.19%) from yesterday's end of day stock price of $1.28.

Biotricity's activity chart (see below) currently has 2 price targets and 7 ratings on display. The stock rating distribution of BTCY is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Highest price target for BTCY is $8, Lowest price target is $1, average price target is $9.82.

Most recent stock forecast was given by KEVIN DEDE from HC WAINWRIGHT on 20-Nov-2023. First documented stock forecast 23-Nov-2021.

Best performing analysts who are covering BTCY - Biotricity:

Kevin Dede Frank Takkinen

Currently out of the existing stock ratings of BTCY, 4 are a BUY (80%), 1 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4

5 months 7 days ago

0/4 (0%)

$1.24 (44.93%)

Buy

24

$22.61 (1626.62%)

30

1 years 9 months 12 days ago

0/2 (0%)

$15.84 (194.12%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BTCY (Biotricity) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on BTCY (Biotricity) with a proven track record?

KEVIN DEDE

Which analyst has the current lower performing score on BTCY (Biotricity) with a proven track record?

FRANK TAKKINEN

Which analyst has the most public recommendations on BTCY (Biotricity)?

Kevin Dede has 5 price targets and 4 ratings on BTCY

Which analyst is the currently most bullish on BTCY (Biotricity)?

Frank Takkinen with highest potential upside - $22.61

Which analyst is the currently most reserved on BTCY (Biotricity)?

Kevin Dede with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?